ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,769,000 | -85.2% | 146,800 | -90.7% | 0.58% | -94.4% |
| Q2 2019 | $18,670,000 | -13.8% | 1,586,220 | 0.0% | 10.50% | +7.4% |
| Q1 2019 | $21,652,000 | +33.2% | 1,586,220 | 0.0% | 9.78% | +13.5% |
| Q4 2018 | $16,259,000 | -38.4% | 1,586,220 | 0.0% | 8.62% | -11.8% |
| Q3 2018 | $26,411,000 | -0.9% | 1,586,220 | -5.9% | 9.77% | +4.1% |
| Q2 2018 | $26,642,000 | +24.4% | 1,686,220 | 0.0% | 9.39% | +31.8% |
| Q1 2018 | $21,415,000 | +79.2% | 1,686,220 | +61.5% | 7.12% | +70.6% |
| Q4 2017 | $11,952,000 | -6.5% | 1,043,832 | 0.0% | 4.18% | -19.4% |
| Q3 2017 | $12,787,000 | +7.0% | 1,043,832 | 0.0% | 5.18% | -5.4% |
| Q2 2017 | $11,952,000 | -39.9% | 1,043,832 | +9.2% | 5.48% | -35.8% |
| Q1 2017 | $19,886,000 | -4.0% | 956,041 | -4.0% | 8.53% | -17.9% |
| Q4 2016 | $20,704,000 | -21.3% | 995,396 | +24.0% | 10.39% | -17.3% |
| Q3 2016 | $26,305,000 | +75.3% | 802,724 | +33.6% | 12.56% | +22.5% |
| Q2 2016 | $15,005,000 | +15.5% | 600,929 | +13.3% | 10.26% | +61.4% |
| Q1 2016 | $12,990,000 | -6.4% | 530,416 | +26.3% | 6.36% | +36.7% |
| Q4 2015 | $13,873,000 | – | 419,997 | – | 4.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|